238 related articles for article (PubMed ID: 8243916)
1. [Drug-induced steatosis, phospholipidosis and pseudo-alcoholic liver disorders].
Fréneaux E; Pessayre D
Gastroenterol Clin Biol; 1993; 17(5 Pt 2):H36-43. PubMed ID: 8243916
[No Abstract] [Full Text] [Related]
2. [Physiopathology of drug-induced hepatopathies].
Pessayre D
Gastroenterol Clin Biol; 1993; 17(5 Pt 2):H3-17. PubMed ID: 8243914
[No Abstract] [Full Text] [Related]
3. Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates.
Donato MT; Gómez-Lechón MJ
Curr Drug Metab; 2012 Oct; 13(8):1160-73. PubMed ID: 22746303
[TBL] [Abstract][Full Text] [Related]
4. [Chronic drug-induced hepatopathies. Imputability and clinical aspects].
Valla D
Gastroenterol Clin Biol; 1995; 19(5 Pt 2):B63-6. PubMed ID: 8522104
[No Abstract] [Full Text] [Related]
5. Amiodarone-induced hepatic phospholipidosis: a morphological alteration independent of pseudoalcoholic liver disease.
Guigui B; Perrot S; Berry JP; Fleury-Feith J; Martin N; Métreau JM; Dhumeaux D; Zafrani ES
Hepatology; 1988; 8(5):1063-8. PubMed ID: 3417226
[TBL] [Abstract][Full Text] [Related]
6. [Drug-induced reactions of infantile liver].
Klinge O
Monatsschr Kinderheilkd (1902); 1979 Mar; 127(3):115-8. PubMed ID: 423898
[No Abstract] [Full Text] [Related]
7. Drug hepatotoxicity.
Timbrell JA
Br J Clin Pharmacol; 1983 Jan; 15(1):3-14. PubMed ID: 6342638
[No Abstract] [Full Text] [Related]
8. Investigating the role of endogenous opioid system in chloroquine-induced phospholipidosis in rat liver by morphological, biochemical and molecular modelling studies.
Malek MR; Ahmadian S; Dehpour AR; Ebrahim-Habibi A; Shafizadeh M; Kashani-Amin E
Clin Exp Pharmacol Physiol; 2020 Sep; 47(9):1575-1583. PubMed ID: 32367550
[TBL] [Abstract][Full Text] [Related]
9. [Liver lesions caused by drugs and environmental pollutants. Free radicals and reactive metabolites. I].
Mariani L; Baratelli M
Clin Ter; 1982 Nov; 103(3):237-65. PubMed ID: 7151380
[No Abstract] [Full Text] [Related]
10. Morphologic studies on secondary phospholipidosis in human liver.
De la Iglesia FA; Feuer G; Takada A; Matsuda Y
Lab Invest; 1974 Apr; 30(4):539-49. PubMed ID: 4824328
[No Abstract] [Full Text] [Related]
11. Drugs and the liver: a review of metabolism and adverse reactions.
Schaffner F; Raisfeld IH
Adv Intern Med; 1969; 15():221-51. PubMed ID: 4908619
[No Abstract] [Full Text] [Related]
12. [Drug-induced liver lesions].
Haas P
Hippokrates; 1970 Sep; 41(3):378-84. PubMed ID: 5473617
[No Abstract] [Full Text] [Related]
13. A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis.
García-Cañaveras JC; Peris-Díaz MD; Alcoriza-Balaguer MI; Cerdán-Calero M; Donato MT; Lahoz A
Electrophoresis; 2017 Sep; 38(18):2331-2340. PubMed ID: 28512733
[TBL] [Abstract][Full Text] [Related]
14. [Biochemical mechanism of the etiology of alcoholic fatty liver and hepatitis].
Ishii H
Nihon Rinsho; 1976 Nov; 34(11):3168-73. PubMed ID: 827624
[No Abstract] [Full Text] [Related]
15. [The liver and drugs].
Nicolae B; Neamţu L
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983; 35(2):97-106. PubMed ID: 6139865
[No Abstract] [Full Text] [Related]
16. [Drug lesions of the liver].
Chernev K
Vutr Boles; 1985; 24(6):17-22. PubMed ID: 3913142
[No Abstract] [Full Text] [Related]
17. Fatty change.
Thaler H
Baillieres Clin Gastroenterol; 1988 Apr; 2(2):453-62. PubMed ID: 3044470
[No Abstract] [Full Text] [Related]
18. [Hepatitis caused by drugs. I].
Valerdiz Casasola S; Linares Rodríguez A; Recarte Alvarez J; Rodrigo Sáez L
Rev Esp Enferm Apar Dig; 1982 Jul; 62(1):74-82. PubMed ID: 6753061
[No Abstract] [Full Text] [Related]
19. [Toxic and nutritional liver damage].
Domschke W
Fortschr Med; 1972 Oct; 90(28):999-1002. PubMed ID: 4658471
[No Abstract] [Full Text] [Related]
20. Drug-induced liver disease: an overview.
Zimmerman HJ
Semin Liver Dis; 1981 May; 1(2):93-103. PubMed ID: 7051299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
